Global Genomics Group LLC G3 is a life sciences company that develops diagnostics and therapeutics by leveraging genomic and molecular disease profiles. It identifies novel biomarkers and therapeutic targets by investigating the biological networks that lead to the development of disease. The company creates the digital models of biological pathways, to unravel the mysteries of human diseases. G3 investigates the development and progression of conditions such as atherosclerosis in cardiovascular disease, diabetes, fatty liver disease, and others by combining precision phenotyping with panomics and systemsbiology driven bioinformatics. The company works in partnership with Sanofi, Omixon, and Caprion Proteomics, Inc. to investigate novel biological networks and pathways. G3 is headquartered in Richmond, Virginia, the US.
